218 related articles for article (PubMed ID: 10959730)
21. [Update on plague in Madagascar].
Chanteau S; Rahalison L; Duplantier JM; Rasoamanana B; Ratsitorahina M; Dromigny JA; Laventure S; Duchemin JB; Boisier P; Rabeson D; Roux J
Med Trop (Mars); 1998; 58(2 Suppl):25-31. PubMed ID: 9812306
[TBL] [Abstract][Full Text] [Related]
22. [Contribution towards plague diagnosis].
de Almeida AM; de Souza GT; Santos S; Silva SC; Petribú Mde M; Haver Pde O; Aragão AI; Tavares C
Rev Soc Bras Med Trop; 2007; 40(1):53-5. PubMed ID: 17486254
[TBL] [Abstract][Full Text] [Related]
23. Comparison of passive haemagglutination and enzyme-linked immunosorbent assay for serodiagnosis of plague.
Williams JE; Arntzen L; Robinson DM; Cavanaugh DC; Isaäcson M
Bull World Health Organ; 1982; 60(5):777-81. PubMed ID: 6758973
[TBL] [Abstract][Full Text] [Related]
24. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
[TBL] [Abstract][Full Text] [Related]
25. [Development of an immunochromayography assay method for the detection of Yersinia pestis].
Zhu H; Zhang CH; Tan H; He J; Zhao B; Duan Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Mar; 27(3):253-5. PubMed ID: 16792900
[TBL] [Abstract][Full Text] [Related]
26. [Clone expression of the caf1 gene of Yersinia pestis and immunological evaluation on recombinant F1 antigen].
Wang P; Shi GX; Wang HB; Yu DZ; Zhang JZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jan; 31(1):69-72. PubMed ID: 20302703
[TBL] [Abstract][Full Text] [Related]
27. Serodiagnosis of human plague by an anti-F1 capsular antigen specific IgG/IgM ELISA and immunoblot.
Neubauer H; Rahalison L; Brooks TJ; Aleksic S; Chanteau S; Splettstösser WD
Epidemiol Infect; 2000 Dec; 125(3):593-7. PubMed ID: 11218210
[TBL] [Abstract][Full Text] [Related]
28. Development and evaluation of two simple, rapid immunochromatographic tests for the detection of Yersinia pestis antibodies in humans and reservoirs.
Rajerison M; Dartevelle S; Ralafiarisoa LA; Bitam I; Dinh TN; Andrianaivoarimanana V; Nato F; Rahalison L
PLoS Negl Trop Dis; 2009; 3(4):e421. PubMed ID: 19399164
[TBL] [Abstract][Full Text] [Related]
29. A rapid field test for sylvatic plague exposure in wild animals.
Abbott RC; Hudak R; Mondesire R; Baeten LA; Russell RE; Rocke TE
J Wildl Dis; 2014 Apr; 50(2):384-8. PubMed ID: 24484483
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar.
Boisier P; Rahalison L; Rasolomaharo M; Ratsitorahina M; Mahafaly M; Razafimahefa M; Duplantier JM; Ratsifasoamanana L; Chanteau S
Emerg Infect Dis; 2002 Mar; 8(3):311-6. PubMed ID: 11927030
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of three serological tests for the detection of human plague in northeast Brazil.
de Almeida AM; Ferreira LC
Mem Inst Oswaldo Cruz; 1992; 87(1):87-92. PubMed ID: 1308559
[TBL] [Abstract][Full Text] [Related]
32. Molecular detection of Yersinia pestis isolates of Indian origin by using Pla specific monoclonal antibodies.
Mahesh S; Shukla J; Tuteja U; Batra HV
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):131-44. PubMed ID: 15582689
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
Gupta G; Khan AA; Rao DN
Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
[TBL] [Abstract][Full Text] [Related]
34. Development of an up-converting phosphor technology-based 10-channel lateral flow assay for profiling antibodies against Yersinia pestis.
Hong W; Huang L; Wang H; Qu J; Guo Z; Xie C; Zhu Z; Zhang Y; Du Z; Yan Y; Zheng Y; Huang H; Yang R; Zhou L
J Microbiol Methods; 2010 Nov; 83(2):133-40. PubMed ID: 20801166
[TBL] [Abstract][Full Text] [Related]
35. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.
Powell BS; Andrews GP; Enama JT; Jendrek S; Bolt C; Worsham P; Pullen JK; Ribot W; Hines H; Smith L; Heath DG; Adamovicz JJ
Biotechnol Prog; 2005; 21(5):1490-510. PubMed ID: 16209555
[TBL] [Abstract][Full Text] [Related]
36. Quantification of low abundance Yersinia pestis markers in dried blood spots by immuno-capture and quantitative high-resolution targeted mass spectrometry.
Rifflet A; Filali S; Chenau J; Simon S; Fenaille F; Junot C; Carniel E; Becher F
Eur J Mass Spectrom (Chichester); 2019 Jun; 25(3):268-277. PubMed ID: 31096787
[TBL] [Abstract][Full Text] [Related]
37. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
38. Trends of Human Plague, Madagascar, 1998-2016.
Andrianaivoarimanana V; Piola P; Wagner DM; Rakotomanana F; Maheriniaina V; Andrianalimanana S; Chanteau S; Rahalison L; Ratsitorahina M; Rajerison M
Emerg Infect Dis; 2019 Feb; 25(2):220-228. PubMed ID: 30666930
[TBL] [Abstract][Full Text] [Related]
39. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982.
Williams JE; Arntzen L; Tyndal GL; Isaäcson M
Bull World Health Organ; 1986; 64(5):745-52. PubMed ID: 3492308
[TBL] [Abstract][Full Text] [Related]
40. Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen.
Tsui PY; Tsai HP; Chiao DJ; Liu CC; Shyu RH
Appl Microbiol Biotechnol; 2015 Sep; 99(18):7781-9. PubMed ID: 25994256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
